New drug licenses in first half dwindled sharply

Published: 2002-07-10 07:00:00

Updated: 2002-07-10 07:00:00

The Korea Food and Administration (KFDA) says new drug licenses in the first half of this year totaled 389 from 121 pharmaceutical firms, a whopping decrease of 45.3 percent over the same period of last year (712 items). Of the licenses, OTCs accounted for 212, prescription drugs for 155, and raw...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK